A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants ; volume:29 ; number:1 ; day:7 ; month:7 ; year:2022 ; pages:1-13 ; date:12.2022
Journal of biomedical science ; 29, Heft 1 (7.7.2022), 1-13, 12.2022
- Urheber
-
Lee, I-Jung
Sun, Cheng-Pu
Wu, Ping-Yi
Lan, Yu-Hua
Wang, I-Hsuan
Liu, Wen-Chun
Yuan, Joyce Pei-Yi
Chang, Yu-Wei
Tseng, Sheng-Che
Tsung, Szu-I
Chou, Yu-Chi
Kumari, Monika
Lin, Yin-Shiou
Chen, Hui-Feng
Chen, Tsung-Yen
Lin, Chih-Chao
Chiu, Chi-Wen
Hsieh, Chung-Hsuan
Chuang, Cheng-Ying
Cheng, Chao-Min
Lin, Hsiu-Ting
Chen, Wan-Yu
Hsu, Fu-Fei
Hong, Ming-Hsiang
Liao, Chun-Che
Chang, Chih-Shin
Liang, Jian-Jong
Ma, Hsiu-Hua
Chiang, Ming-Tsai
Liao, Hsin-Ni
Ko, Hui-Ying
Chen, Liang-Yu
Ko, Yi-An
Yu, Pei-Yu
Yang, Tzu-Jing
Chiang, Po-Cheng
Hsu, Shang-Te
Lin, Yi-Ling
Lee, Chong-Chou
Wu, Han-Chung
Tao, Mi-Hua
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12929-022-00830-1
- URN
-
urn:nbn:de:101:1-2022082920291977515830
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, I-Jung
- Sun, Cheng-Pu
- Wu, Ping-Yi
- Lan, Yu-Hua
- Wang, I-Hsuan
- Liu, Wen-Chun
- Yuan, Joyce Pei-Yi
- Chang, Yu-Wei
- Tseng, Sheng-Che
- Tsung, Szu-I
- Chou, Yu-Chi
- Kumari, Monika
- Lin, Yin-Shiou
- Chen, Hui-Feng
- Chen, Tsung-Yen
- Lin, Chih-Chao
- Chiu, Chi-Wen
- Hsieh, Chung-Hsuan
- Chuang, Cheng-Ying
- Cheng, Chao-Min
- Lin, Hsiu-Ting
- Chen, Wan-Yu
- Hsu, Fu-Fei
- Hong, Ming-Hsiang
- Liao, Chun-Che
- Chang, Chih-Shin
- Liang, Jian-Jong
- Ma, Hsiu-Hua
- Chiang, Ming-Tsai
- Liao, Hsin-Ni
- Ko, Hui-Ying
- Chen, Liang-Yu
- Ko, Yi-An
- Yu, Pei-Yu
- Yang, Tzu-Jing
- Chiang, Po-Cheng
- Hsu, Shang-Te
- Lin, Yi-Ling
- Lee, Chong-Chou
- Wu, Han-Chung
- Tao, Mi-Hua
- SpringerLink (Online service)
Ähnliche Objekte (12)
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Clinical characteristics and booster vaccine effectiveness of the Omicron variant
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Clinical characteristics and booster vaccine effectiveness of the Omicron variant
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Clinical characteristics and booster vaccine effectiveness of the Omicron variant
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes